Taken together, these findings suggest that BiHANs exert their anti-inflammatory effects, at least in part, by targeting mitochondria, preserving mitochondrial homeostasis, reducing oxidative stress, and suppressing NF-κB signalling, thereby mitigating intestinal inflammation in IBD. This evidence concerns the gene NFKB1 and inflammatory bowel disease.